XML 70 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share of Common Stock (Tables)
12 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Reconciliation of Numerator and Denominator for Basic and Diluted Earnings (Loss) Per Share Calculation

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings (loss) per share calculation for the periods indicated:

 

Fiscal Year Ended

 

 

September 30, 2025

 

 

September 30, 2024

 

 

September 30, 2023

 

Basic Earnings (Loss) per common share

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Net income

$

56.0

 

 

$

66.4

 

 

$

(7.7

)

 Less: dividends on Series A convertible preferred shares

 

(35.8

)

 

 

(35.7

)

 

 

(3.2

)

 Less: Earnings allocated to Convertible Preferred Shares

 

(7.4

)

 

 

(11.2

)

 

 

 

Net income (loss) available to common shareholders

$

12.8

 

 

$

19.5

 

 

$

(10.9

)

Denominator:

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding – basic

 

95,170,000

 

 

 

94,673,000

 

 

 

93,412,000

 

Basic earnings per share

$

0.13

 

 

$

0.21

 

 

$

(0.12

)

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per common share

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Net income (loss) available to common shareholders – diluted

$

12.8

 

 

$

19.5

 

 

$

(10.9

)

Denominator:

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding – basic

 

95,170,000

 

 

 

94,673,000

 

 

 

93,412,000

 

Dilutive effect of:

 

 

 

 

 

 

 

 

Stock compensation awards

 

1,333,000

 

 

 

1,403,000

 

 

 

 

Weighted average number of common shares outstanding – diluted

 

96,503,000

 

 

 

96,076,000

 

 

 

93,412,000

 

Diluted earnings per share

$

0.13

 

 

$

0.20

 

 

$

(0.12

)

Other Information:

 

 

 

 

 

 

 

 

Weighted average number of anti-dilutive Series A convertible preferred shares, options and restricted stock(a)

 

57,369,000

 

 

 

56,587,000

 

 

 

9,656,000

 

 

(a)
Weighted average number of anti-dilutive options is based upon the average closing price of the Company’s common stock on the NYSE for the period.